Brihans Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.53 Cr
as on 12-12-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.08 M
as on 12-12-2024
- Revenue 23.85%
(FY 2021)
- Profit 0.57%
(FY 2021)
- Ebitda -6.69%
(FY 2021)
- Net Worth -56.34%
(FY 2021)
- Total Assets -19.84%
(FY 2021)
About Brihans Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.53 Cr.
The company has closed loans amounting to ₹1.08 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Kothari and Udai Kothari serve as directors at the Company.
- CIN/LLPIN
U24100MH2009PTC304954
- Company No.
304954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2009
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Brihans Laboratories Private Limited offer?
Brihans Laboratories Private Limited offers a wide range of products and services, including Nutritional Supplements, Nutritional Vitamin Supplements, Hair Shampoo, Aloe Vera Shampoo, Aloe Vera Cosmetics, Aloe Vera Hair Conditioner, Herbal Juice, Aloe Vera Juice, Lemon Shampoo, Hair Care Products.
Who are the key members and board of directors at Brihans Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Kothari  | Director | 29-Apr-2009 | Current |
| Udai Kothari | Director | 29-Apr-2009 | Current |
Financial Performance and Corporate Structure Insights of Brihans Laboratories.
Brihans Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 23.85% increase. The company also saw a slight improvement in profitability, with a 0.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 56.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brihans Laboratories?
In 2021, Brihans Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
U.Y. Aviation Private LimitedActive 9 years 7 monthsDeepak Kothari and Udai Kothari are mutual person
Lotus Capital Financial Services LimitedActive 29 years 3 monthsDeepak Kothari and Udai Kothari are mutual person
U.Y. Industries Private Limited (Trf.)Active 26 years 6 monthsDeepak Kothari and Udai Kothari are mutual person
Somdatt Landmark Golf Clubs & Resorts Private LimitedActive 8 years 3 monthsDeepak Kothari is a mutual person
- Som Datt Landmark Hotels & Recreations Private LimitedActive 15 years 24 days
Deepak Kothari is a mutual person
Brima Sagar Maharashtra Distilleries LimitedActive 16 years 5 monthsDeepak Kothari and Udai Kothari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2018 | ₹1.08 M | Satisfied |
How Many Employees Work at Brihans Laboratories?
Brihans Laboratories has a workforce of 127 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brihans Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brihans Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
